Filing Details

Accession Number:
0001638599-20-000118
Form Type:
4
Zero Holdings:
No
Publication Time:
2020-02-03 17:13:52
Reporting Period:
2019-09-30
Accepted Time:
2020-02-03 17:13:52
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1682639 Eyenovia Inc. EYEN Pharmaceutical Preparations (2834) 471178401
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1744774 M Michael Rowe C/O Eyenovia, Inc.
295 Madison Avenue, Suite 2400
New York NY 10017
Vice President, Commercial No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $.0001 Acquisiton 2019-09-30 100 $3.84 1,400 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (right to buy) $6.30 2028-07-02 60,000 60,000 Direct
Common Stock Stock Option (right to buy) $6.20 2028-07-24 19,874 19,874 Direct
Common Stock Stock Option (right to buy) $3.11 2029-08-16 42,722 42,722 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-07-02 60,000 60,000 Direct
2028-07-24 19,874 19,874 Direct
2029-08-16 42,722 42,722 Direct
Footnotes
  1. The option became exercisable as to 1,666 shares on August 2, 2018 and becomes exercisable in equal 1,666 share amounts on each of the 35 one-month anniversaries thereafter.
  2. One-third of the option became exercisable on July 24, 2019 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.
  3. One-third of the option becomes exercisable on August 16, 2020 and the remaining shares underlying the option become exercisable in equal increments on each of the 24 one-month anniversaries thereafter.